Effects of an Alkaline Diet on EGFR-TKI Therapy in EGFR Mutation-positive NSCLC

被引：19

作者：

Hamaguchi, Reo ^{[1
]}

Okamoto, Toshihiro ^{[2
]}

Sato, Masaaki ^{[1
]}

Hasegawa, Michiko ^{[1
]}

Wada, Hiromi ^{[1
]}

机构：

[1] Karasuma Wada Clin, Yasaka Karasuma Oike Bldg 2F, Kyoto, Japan

[2] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA

来源：

ANTICANCER RESEARCH | 2017年 / 37卷 / 09期

关键词：

Non-small cell lung cancer; EGFR mutation; low dose EGFR-TKI; alkaline diet; fruit and vegetables; pH regulation; urine pH; tumor microenvironment; Na+/H+ exchanger; CELL LUNG-CANCER; 1ST-LINE TREATMENT; PROTEOMIC ANALYSIS; OPEN-LABEL; URINE PH; GEFITINIB; ADENOCARCINOMA; CHEMOTHERAPY; METAANALYSIS; PACLITAXEL;

D O I：

10.21873/anticanres.11934

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: The acidic tumor microenvironment is associated with progression of cancers. The purpose of this study was to investigate the association between an alkaline diet and the effect of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) in non-small cell lung cancer (NSCLC) patients. Patients and Methods: Eleven advanced or recurrent NSCLC patients with EGFR mutations treated with EGFR-TKI after being instructed to follow an alkaline diet were retrospectively evaluated. Results: The median progression-free survival (PFS) and overall survival (OS) were 19.5 (range= 3.1-33.8) and 28.5 (range= 15.4-46.6) months. The average dosage of EGFR-TKI was 56 +/- 22% of the standard dosage. Urine pH was significantly increased after the alkaline diet (6.00 +/- 0.38 vs. 6.95 +/- 0.55; p< 0.05). Conclusion: An alkaline diet may enhance the effect of EGFR-TKI treatment in NSCLC patients with EGFR mutations.

引用

页码：5141 / 5145

页数：5

共 24 条

[1] Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis
Amith, Schammim R.
Fliegel, Larry
[J]. CANCER RESEARCH, 2013, 73 (04) : 1259 - 1264
[2] Vegetables and fruits in relation to cancer risk: Evidence from the Greek EPIC cohort study
Benetou, Vassiliki
Orfanos, Philippos
Lagiou, Pagona
Trichopoulos, Dimitrios
Boffetta, Paolo
Trichopoulou, Antonia
[J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (02) : 387 - 392
[3] FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR
Bivona, Trever G.
Hieronymus, Haley
Parker, Joel
Chang, Kenneth
Taron, Miquel
Rosell, Rafael
Moonsamy, Philicia
Dahlman, Kimberly
Miller, Vincent A.
Costa, Carlota
Hannon, Gregory
Sawyers, Charles L.
[J]. NATURE, 2011, 471 (7339) : 523 - 526
[4] Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, Andrea
Puntoni, Matteo
Goodwin, Pamela
Cazzaniga, Massimiliano
Gennari, Alessandra
Bonanni, Bernardo
Gandini, Sara
[J]. CANCER PREVENTION RESEARCH, 2010, 3 (11) : 1451 - 1461
[5] Hirano Ryosuke, 2016, Asian Pac J Cancer Prev, V17, P785
[6] Isobe K, 2015, CANCER GENOM PROTEOM, V12, P31
[7] Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Kanda, Y.
[J]. BONE MARROW TRANSPLANTATION, 2013, 48 (03) : 452 - 458
[8] Fruit and vegetables and cancer risk
Key, T. J.
[J]. BRITISH JOURNAL OF CANCER, 2011, 104 (01) : 6 - 11
[9] Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
Lee, Chee Khoon
Brown, Chris
Gralla, Richard J.
Hirsh, Vera
Thongprasert, Sumitra
Tsai, Chun-Ming
Tan, Eng Huat
Ho, James Chung-Man
Chu, Da Tong
Zaatar, Adel
Osorio Sanchez, Jemela Anne
Vu Van Vu
Au, Joseph Siu Kie
Inoue, Akira
Lee, Siow Ming
Gebski, Val
Yang, James Chih-Hsin
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (09): : 595 - 605
[10] A mathematical model of tumour and blood pHe regulation: The HCO3-/CO2 buffering system
Martin, Natasha K.
Gaffney, Eamonn A.
Gatenby, Robert A.
Gillies, Robert J.
Robey, Ian F.
Maini, Philip K.
[J]. MATHEMATICAL BIOSCIENCES, 2011, 230 (01) : 1 - 11

← 1 2 3 →